ASCEPT, APFP & APSA Joint Congress 2024

Location: Melbourne, Australia

Date:

Event description:

Novotech will participate in the inaugural joint congress hosted by the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), the Asia Pacific Federation of Pharmacologists (APFP), and the Australasian Pharmaceutical Science Association (APSA) in Melbourne, Australia from December 1-4, 2024. The congress will bring together professionals across pharmacology, toxicology, pharmaceutical sciences, and clinical sciences. 

Join us at Novotech’s table to connect with our Drug Development Consulting, which provides end-to-end support from discovery to registration. 

Presentations: 

  • Navigating the Valley of Threats: Bringing a Potential Therapeutic from Candidate to the Clinic 

When: Sunday, Dec. 1, 11:15 – 1:15 in Eureka Room 2. 

Presented by Dr. Karen Scalzo-Inguanti and Dr. Melisa Anggraeni and chaired by Dr. Felicity Grzemski.

  • Poster Presentation: Navigating the Challenges of Cell and Gene Therapies - Nonclinical and Manufacturing Considerations 

Dr. Sharleen Menezes’ poster will be on display from December 2-4, under the Innovation and Industry theme, Paper #181. Sharleen will present on her poster: 

  • Monday, Dec. 2: 10:30 - 11:10 and 13:15 - 14:10. 
  • Tuesday, Dec. 3: 10:30 - 11:10 and 13:15 - 14:10. 
  • Wednesday, Dec. 4: 09:50 - 10:25, with student poster finalists from 12:30 – 13:25. 

Schedule a meeting with our attendees

Meet Our Team

Drug Development Consulting

Dr. Felicity Grzemski

Drug Development Consulting
Toxicology Director

Dr. Karen Scalzo-Inguanti

Senior Therapeutic Strategy Manager
Novotech

Dr. Sharleen Menezes

Novotech
Senior Toxicologist
Novotech

Dr. Melisa Anggraeni

Novotech
Senior Scientific Consultant
Novotech DDC

Melissa Dworak

Novotech DDC
Toxicologist

Plus experts from our China, Drug Development, and global Commercial teams.